Hospital General Universitario Dr. Balmis — Clinical Trial Site

275 Registered trials

112 Currently recruiting

Organisation

Hospital General Universitario Dr. Balmis

Location

Alicante, Spain

Identifier

ORG-100032714

Address

Avinguda Del Pintor Baeza 12, 03010, Spain

Departments

-
#40750: Dermatología
#7009: Hematología
1103: Dermatología
1402:Dermatología
172420: Hematología
2743; Dermatología
2801:Dermatología
2906: Hematology
3006; Enfermedades Infecciosas
40750: Dermatología
6505: Dermatología
7002: Oncología
7013:Oncología
7223: Neurology
9753; Dermatología
Allergology
Allergy
Anaesthesiology
Anesthesiology Service
Cardiología
Cardiology
Cardiovascular Surgery Department
Departamento de dermatologia
Departamento de Medicina Digestiva
Dept of Haemostasis and Thrombosis
Dermathology unit
Dermatologia
Dermatology
Dermatology department
Dermatology, Venereology
Digestive system
Emergencies
Endocrinology
Enfermedades Infecciosas
ES10008: Aparato Digestivo
ES30009: Hematología
ESP05444: Dermatology
Gastroenterology
Gastroentological Department
Haematology Department
Hematología
Hematology
Infectious Disease
Infectious Diseases
Infectious Diseases Unit
Maxilofacial
Medical oncologist
Medical Oncology
N/A
NA
Neonatology
Neurología
Neurology
Neurology Department
Obstetrician and Gynecologist
ONCOLGIA
Oncología
Oncología Médica
Oncology
Oncology Department
Oncology Department
Oncology Service
ORL
Paediatric Emergencies
Pediatric Oncology
Pediatric oncology and hematology
Pediatric oncology and hematology department
Pediatric oncology department
Pneumology
Radiodiagnosis Service - Interventional Neuroradiology Unit
Reumatología
Servicio de digestivo
Servicio de Cardiologia. Consultas externas, 5ª planta. Ensayos clinicos de Cardiologia
Servicio de Dermatologia
Servicio de Digestivo
Servicio de Endocrinología
Servicio de Enfermedades Infecciosas
Servicio de Hemotología
Servicio de Medicina Digestiva
Servicio de Neonatologia
Servicio de Neumología
Servicio de Neurología
Servicio de Oncología
Servicio de Oncología y Hematología Pediátricas
Unidad de Ecografía Ginecológica
Unidad de Enfermedades Infecciosas
Unidad de Infecciosas
Unidad de Oncologica Pediatrica
xxx

Clinical trials at this site (275)

Search interface

A PHASE 1/2 STUDY OF ALX148 IN COMBINATION WITH AZACITIDINE IN PATIENTS WITH HIGHER RISK MYELODYSPLASTIC SYNDROME (MDS) (ASPEN-02) Ended

2024-513993-23-00 Patients with higher risk myelodysplastic syndrome (MDS 9 2022-09-21
A Study of Eptinezumab in Participants With Migraine and Medication Overuse Headache Ended

2024-510729-24-00 Chronic Migrane, Migrane, Medication Overuse Headache 6 2022-09-01
Tralokinumab monotherapy for children with moderate-to-severe atopic dermatitis. Ended

2024-512791-36-00 Treatment of moderate-to-severe Atopic dermatitis 4 2022-08-24
Adjusted brodalumab dose compared with standard brodalumab dose in subjects with moderate-to-severe plaque psoriasis and ≥120 kg body weight… Ended

2023-509668-11-00 Moderate-to-severe plaque psoriasis and a body weight ≥ 6 2022-06-15
Clinical trial developed at various hospitals where each patient randomly receive in parallel groups either placebo or treatment. Nor patien… Ended

2024-519527-14-00 Allergic rhinoconjunctivitis 5 2022-06-09
ATILA Project: Aspirin Versus Tirofiban in Endovascular Treatment for Patients With Acute Ischemic Stroke Due to Tandem Lesion Ended

2023-508454-26-00 Acute Ischemic Stroke 6 2022-05-01
A Phase 3, randomized, double-blind, placebo-controlled, multicenter study of IV FDY-5301 in patients with a myocardial infarction (STEMI) Ended

2024-514372-40-00 Anterior ST-Elevation Myocardial Infarction 5 2022-04-12
Advanced hormone receptor-positive/HER2-negative/HER2-Enriched breast cancer Ended

2023-508828-35-01 Patients with advanced hormone receptor-positive/HER2- 5 2022-03-28
Predicting olaparib sensitivity in metastatic HER2-negative breast cancer with BRCA1, BRCA2, PALB2, RAD51C or RAD51D mutation or RAD51-negat… Ended

2024-511875-14-00 Pre and post-menopausal women and men with unresectable 4 2022-03-24
CO-THEIA (COMBINATION THERAPY WITH METHOTREXATE AND ADALIMUMAB FOR UVEITIS): EFFICACY, SAFETY AND COST-EFFECTIVENESS OF METHOTREXATE, ADALIM… Ended

2024-513123-17-00 Non-infection uveitis 5 2022-01-12
Randomised, double-blind, placebo-controlled study to evaluate the effect of metformin, an AMPK activator, on cognitive measures of progress… Ended

2024-518875-73-00 Huntington Disease 5 2021-12-10
A phase III trial of trastuzumab + ALpelisib +/- fulvestrant versus trastuzumab + chemotherapy in patients with PIK3CA mutated previously tr… Ended

2024-514611-98-00 PIK3CA mutated HER2+ advanced or relapsed breast cancer 5 2021-07-20
A study designed to evaluate a modified Anti-Platelet Therapy (drugs that preventblood platelets from clotting) after implantation of a Fire… Ended

2024-519854-35-00 Acute Myocardial Infarction 6 2021-06-29
DTG/3TC vs BIC/FTC/TAF maintenance therapy in people living with HIV: an open-label randomized clinical trial Ended

2024-515167-56-00 HIV 11 2021-06-22
Study of Atezolizumab plus chemotherapy plus chemo-radiotherapy and Atezolizumab maintenance therapy in non-resectable non-small cell lung c… Ended

2024-514803-33-00 Non-small cell lung cancer (NSCLC) 4 2021-06-16
HOPE study Ended

2024-516642-19-01 Acute Ischemic Stroke 6 2021-06-16
A trial to assess the long-term safety of octreotide subcutaneous depot in patients with acromegaly Ended

2024-510667-33-00 Acromegaly 5 2021-06-03
Assessment of the Efficacy, Safety, and Tolerability of AVP-786 for the Treatment of Agitation in Patients With Dementia of the Alzheimer's … Ended

2023-504991-31-00 Agitation in Patients With Dementia of the Alzheimer's 5 2021-05-06
A randomized, 2-arm, open-label, phase II study of abemaciclib combined with endocrine therapy (letrozole or fulvestrant) with or without a … Ended

2023-509591-42-00 HR-positive/HER2-negative breast cancer 4 2021-05-04
Polatuzumab vedotin plus rituximab, ifosfamide, carboplatin and etoposide (Pola-R-ICE) versus R-ICE alone in second line treatment of diffus… Ended

2023-508259-38-00 Adult patients with relapsed or primary refractory DLBC 5 2021-04-29
Study to evaluate the effect of metformin in the prevention of hyperglycemia in HR[+]/HER2[–] PIK3CA-mutated advanced breast cancer patients… Ended

2024-511295-33-00 Study to evaluate the effect of metformin in the preven 4 2020-08-13
Clinical trial to assess the efficacy and safety of a vaccine for dust mite allergy Ended

2024-514090-21-00 Aetiological treatment of moderate - severe intermitten 5 2020-08-05
A Study of Tiragolumab, an Anti-TIGIT Antibody, in Combination with Atezolizumab Compared with Placebo in Combination with Atezolizumab (an … Ended

2022-502482-17-00 Non-small cell lung cancer (NSCLC) 5 2020-05-19
The Late Presenter Treatment Optimisation Study (LAPTOP) Ended

2023-505167-36-00 Patients who present late on during their acquisition o 5 2019-08-05